Status and developmental trends in recombinant collagen preparation technology
Regenerative Biomaterials · 02.01.2024 · 11
DOI: 10.1093/rb/rbad106 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Regenerative Biomaterials, online erschienen am 29.11.2023. Verfasst von Xiaolei Guo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Medical Device Evaluation, National Medical Products Administration, Beijing 100081, China. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Drug Regulatory Science Action Plan, National Medical Products Administration.
Abstract (Originalsprache)
Recombinant collagen is a pivotal topic in foundational biological research and epitomizes the application of critical bioengineering technologies. These technological advancements have profound implications across diverse areas such as regenerative medicine, organ replacement, tissue engineering, cosmetics and more. Thus, recombinant collagen and its preparation methodologies rooted in genetically engineered cells mark pivotal milestones in medical product research. This article provides a comprehensive overview of the current genetic engineering technologies and methods used in the production of recombinant collagen, as well as the conventional production process and quality control detection methods for this material. Furthermore, the discussion extends to foresee the strides in physical transfection and magnetic control sorting studies, envisioning an enhanced preparation of recombinant collagen-seeded cells to further fuel recombinant collagen production.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Medical Device Evaluation, National Medical Products Administration, Beijing 100081, China.
- State Key Laboratory of Tribology, Tsinghua University, Beijing 100084, China.
- School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China.
- National Engineering Research Center for Biomaterials & College of Biomedical Engineering, Sichuan University, Chengdu 610064, China.
- Biotech. & Biomed. Research Institute, Northwest University, Xi'an 710127, China.
ORCID-Profile: Xiaolei Guo
Förderung
- China Drug Regulatory Science Action Plan
- National Medical Products Administration
Zitieren
APA
Guo, X., Ma, Y., Wang, H., Yin, H., Shi, X., Chen, Y., Gao, G., Sun, L., Wang, J., Wang, Y., & Fan, D. (2024). Status and developmental trends in recombinant collagen preparation technology. Regenerative Biomaterials, 11. https://doi.org/10.1093/rb/rbad106
Vancouver
Guo X, Ma Y, Wang H, Yin H, Shi X, Chen Y, et al. Status and developmental trends in recombinant collagen preparation technology. Regenerative Biomaterials. 2024;11. doi:10.1093/rb/rbad106
BibTeX
@article{Guo2024,
author = {Guo, Xiaolei and Ma, Yuan and Wang, Hang and Yin, Hongping and Shi, Xinli and Chen, Yiqin and Gao, Guobiao and Sun, Lei and Wang, Jiadao and Wang, Yunbing and Fan, Daidi},
title = {Status and developmental trends in recombinant collagen preparation technology},
journal = {Regenerative Biomaterials},
year = {2024},
volume = {11},
doi = {10.1093/rb/rbad106}
}
EUVIMED